Clinical Trial Update: Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Pulmicort Respules (budesonide inhalation suspension) to Singulair (montelukast) in children with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Respules (budesonide)
• SINGULAIR (montelukast)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED